EX-10.37 3 dex1037.htm COMPENSATION INFORMATION FOR NAMED EXECUTIVE OFFICERS Compensation information for named executive officers

Exhibit 10.37

 

COMPENSATION INFORMATION FOR NAMED EXECUTIVE OFFICERS

 

The table below provides information regarding the 2005 cash bonus, December 2, 2005 stock option grant, 2006 annual base salary and 2006 target cash bonus of each named executive officer of Kosan Biosciences Incorporated listed below.

 

Executive Officer

    2005 Cash Bonus
   

Stock Option
Grant*

(# shares)

    2006 Annual
Base Salary
    2006 Target
Cash Bonus**
  

Daniel V. Santi, M.D., Ph.D.,

Chief Executive Officer

    $ 105,000    78,750    $ 445,000    45 %

Robert Johnson Jr., M.D., Ph.D.,

Executive Vice President, Development and Chief Medical Officer

    $ 75,000    52,500    $ 365,000    30 %

Susan M. Kanaya,

Senior Vice President, Finance and Chief Financial Officer

    $ 57,000    37,500    $ 305,000    30 %

Margaret A. Horn

Senior Vice President and General Counsel

      N/A    150,000    $ 300,000    30 %
* Granted by the Compensation Committee of the Board of Directors of the Company on December 2, 2005, with an exercise price per share equal to the closing price as reported on the Nasdaq National Market on December 1, 2005.
** Percentage of each named executive officer’s 2006 annual base salary.